Mackie Research has upgraded CARDIOME PHARMA CORP (NASDAQ: CRME) to Speculative Buy from Hold on its recent licensing of Xydalba (Dalbavancin) from Allergan plc Ordinary Shares (NYSE: AGN) for $13 million up front.
The Potential Power Of Dalbavancin
Cardiome will also pay undisclosed "additional...

Analysts at Standpoint Research upgraded POSCO (NYSE: PKX) from Hold to Buy. POSCO shares traded at $72.17 at the time of publication, up 2.15 percent their Friday close at $70.65.
UBS upgraded ITC Holdings (NYSE: ITC) from Neutral to Buy. ITC traded at $88.35 at the time of publication, up 2....

Mackie Research upgraded Eldorado Gold Corporation (NYSE: EGO) from Hold to Buy.
Mackie Research noted, "We had moved ELD to a HOLD rating post its merger with European Goldfields, and continue to believe that the company has strapped on too many development projects, although given the recent...

Mackie Research lowered its rating on IAMGOLD (NYSE: IAG) from Buy to Hold and reduced its price target from $19.50 to $17.
Mackie Research said, "Financial results fall well short of expectations, due more to lower sales: Only 188 Koz of gold was actually sold in 3Q/12, meaning adjusted EPS of...

Off-roading equipment is getting ready to go a little greener following a new agreement between Westport Innovations (NASDAQ: WPRT) and Caterpillar Inc. (NYSE: CAT). Announced early this morning, the budding relationship will serve to co-develop natural gas technology for worker transportation such...